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ABSTRACT 
 
 
This thesis contains three investigations examining gait variability in people with multiple 
sclerosis (MS), which is a neurological disease that can result in significant walking impairment. 
Gait variability, i.e. fluctuations in the mechanics and kinematics of steps during walking, has 
been associated with motor control function, stability and falls in other populations but has not 
been thoroughly documented in people with MS. In this thesis, gait variability is documented in 
different samples of people with MS using a variety of metrics. The first investigation examines 
differences in variability of spatiotemporal gait parameters between people with MS and healthy 
controls and associations between variability of spatiotemporal gait parameters and disability in 
MS. The second investigation determines variability of lower-limb joint and segment angles at 
various walking speeds in MS. The third investigation documents a novel metric for 
quantification of footfall placement variability and subsequent associations between footfall 
variability and fall history in MS. Results herein include greater variability of step length, step 
time, and footfall placement variability in people with MS compared to controls, decrease in 
ankle angle variability with increasing walking velocity in MS, and that increased footfall 
placement variability, indexed by a novel metric, separates recurrent and non fallers with MS. 
Additional research into gait variability in MS is warranted to further evaluate differences 
between MS and controls as well as to investigate underlying factors that may drive gait 
variability in MS. 
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CHAPTER 1 
 
 
 
INTRODUCTION 
 
 
 
1.1 Introduction to Gait Variability in MS 
 
 
 
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) that 
affects approximately 400,000 people in the United States and an estimated 2.5 million people 
world-wide
1
. MS involves demyelination, axonal loss, and formation of lesions in the CNS that 
distort and disrupt action potential conduction
2
. These effects manifest themselves in various 
symptoms including, but not limited to, sensory, cognitive, balance, and gait impairment
1
. MS 
generally does not affect life expectancy but does lead to progressive disability, which results in 
a lower quality of life
3,4
, in large part due to changes in mobility. 70% of persons with MS report 
gait impairment as the most challenging aspect of the disease
5
. Half of people with MS require 
assistive devices for ambulation within the first 15 years of the disease
6
. 
 
Gait impairment in MS is well documented
7
. Individuals with MS walk slower, with reduced 
cadence and step length and spending a greater percent of the gait cycle in double-support 
compared to healthy controls
8-10
. Gait impairment in MS is multi-faceted. Fatigue
11,12
, reduced 
leg muscle strength
13,14
, and spasticity
15
 have all been associated with gait impairment in MS. 
Gait impairment increases with increasing disability
9,16
, commonly indexed in MS by the 
Expanded Disability Status Score (EDSS)
17
. EDSS ranges from 0 (normal neurological exam) to 
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10 (death due to MS), with EDSS>4.5 representing individuals with significant walking 
impairment.  
 
Gait impairment in MS is measured in a variety of ways
18,19
. Clinically, gait is typically assessed 
through timed performance tests such as the timed 25-foot walk, 2-minute, and 6-minute walks
19
. 
In research, gait is additionally measured with motion capture systems
8,11,16
 and instrumented 
walkways
9,10,12
 that provide information about the mechanics of walking to compliment the 
results of timed performance tests.  
 
Variability is inherent to biological function (e.g. heartbeat, respiration), including gait. It is 
maintained that a certain level of variability is indicative of health in most biological systems
20
. 
Too much variability may indicate that deviations are not corrected by the system which can lead 
to instability. Meanwhile, too little variability can indicate that a system is overly rigid and 
potentially unable to respond to perturbations
21
. It has also been suggested that gait variability 
may potentially be more sensitive to dysfunction than mean gait parameters
20
. 
 
Gait variability is a facet of walking behavior that has been garnering more scientific scrutiny in 
recent years
22
. The presence of pathology can cause changes in gait variability because of its 
impact on motor function and control
21
. Gait variability has been associated with instability and 
falls in populations with neurological deficiencies including the elderly
23-26, Alzheimer’s27, and 
Parkinson’s disease28. Others have used gait variability to investigate impact of and recovery 
from various injuries. Researchers have examined changes in gait variability arising from serious 
knee surgeries such as ACL repair
29
 and total knee replacement
30
. Gait variability has also been 
3 
 
studied as evidence of different motor control strategies arising from various forms of 
dysfunction. For example, one report investigated gait variability as a marker for different 
control strategies in children with Down Syndrome versus children with traditional 
development
31
. Others have looked at gait variability in connection to specific areas of 
impairment in the central nervous system
32
, persistent versus anti-persistent control variables in 
healthy gait
33
, and the impact of training on gait variability in runners
34
.  
 
Gait variability has been quantified with a variety of metrics, including quantification of both 
magnitude of variability as well structure of variability in time. Traditionally, variability is 
defined in simple terms such as standard deviation
26,30,35,36
 or coefficient of variation
23-25,27,32,34
 
(CV=100%*SD/mean). Metrics such as standard deviation and CV provide information 
regarding variability magnitude. Other metrics have also been used to quantify the structure of 
gait variability, including detrended fluctuation analysis
33,37
, Lyapunov exponents
29,30
, 
uncontrolled manifold analysis
31
, approximate entropy
38,39
, and analysis of gait phase portraits 
using adapted posturographic measures
40,41
. Structure of variability refers to how variability 
fluctuates in time, rather than the magnitude. Selection of the proper metric for gait variability 
depends on the specific research question and timescale of interest. 
 
Despite growing interest in gait variability in the research community, there has been limited 
documentation of gait variability in MS. It has been demonstrated that persons with MS 
demonstrate greater variability of step length
42
, step time and single-support time
10
 than healthy 
controls. One study showed that people with MS have elevated variability of hip, knee, and ankle 
angles
36
. Another study also demonstrated that cane use causes reduction in gait variability in 
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persons with MS
43
. Overall, contributing factors and clinical significance of gait variability in 
MS remain unclear. Further documentation of gait variability in people with MS is warranted. 
 
In this thesis, three investigations regarding gait variability in MS are presented. In addition to 
looking at differences between people with MS and healthy controls, each study addresses a 
distinct research question and focuses on a distinct method for quantifying gait variability. The 
first study examines correlations between gait variability and disability in MS. The second 
investigates variability of lower limb joint and segment angles through phase portraits of gait at 
different walking speeds. The final study utilizes a novel metric for quantifying footfall 
placement variability and examines subsequent associations between footfall placement 
variability and falls in people with MS. 
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CHAPTER 2 
 
 
 
GAIT VARIABILITY AND DISABILITY IN MULTIPLE SCLEROSIS 
 
 
 
2.1 Abstract 
 
The purpose of this investigation was to examine variability of spatiotemporal gait parameters in 
people with multiple sclerosis (MS). Although gait variability is clinically relevant in various 
populations, there is limited documentation of gait variability in MS. Eighty-eight individuals 
with MS (age 52.4 ± 11.1, 83% female) and 20 healthy controls (age 50.9 ± 8.7, 80% female) 
participated in this investigation. Participants with MS underwent a brief neurological exam to 
determine Expanded Disability Status Scale (EDSS) and all participants performed two self-
paced walking trials on a 7.9 meter GAITRite
TM
 electronic walkway. Gait variability was 
indexed by calculating coefficient of variation (CV=SD/mean) for step time, step length, and 
step width for each participant. Step length and step time variability were both significantly 
greater in the MS group compared to healthy controls (p<0.05). Disability, indexed by EDSS, 
was positively correlated with step length CV (ρ=0.57, p<0.05) and step time CV (ρ=0.40, 
p<0.05) and negatively correlated with step width CV (ρ=-0.35, p<0.05) in persons with MS. 
Gait variability is altered in MS as a function of disability status, and researchers should consider 
the consequences and potential techniques to target altered gait variability in MS. 
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2.2 Introduction 
 
Multiple sclerosis (MS) is a prevalent, autoimmune disease that affects an estimated 400,000 
American adults and 2.5 million adults world-wide. MS results in demyelination and loss of 
axons in the central nervous system. Such CNS damage manifests as muscle weakness, sensory 
loss, and ataxia, and such changes might be associated with walking or gait impairment
1
. 
Disability increases with MS and is typically indexed by the Expanded Disability Status Scale
2
 
(EDSS). 
 
Gait impairment is one of the most frequent consequences of MS, and walking dysfunction is 
considered by the majority of patients as the most challenging, life-altering aspect of the 
disease
3
. Persons with MS walk slower, taking shorter, wider, and slower steps, and spend a 
greater percent of the gait cycle in double-support compared to healthy controls
4-6
, even early in 
the disease course
7,9
. Such changes in gait have been directly associated with disability status as 
a marker of disease progression
6,10
.  
 
In addition to demonstrating different average spatiotemporal parameters of gait, there is some 
evidence that persons with MS have elevated gait variability compared to controls.  For example, 
one study reported that persons with MS exhibit greater kinematic variability at the hip, knee, 
and ankle during ambulation than healthy controls
11
. Other studies have reported that persons 
with MS who had mild impairment demonstrate greater variability of step time and single-
support time
7
 and step length
8
 than age and gender matched controls. Additionally, there is some 
preliminary evidence based on a small sample (n=10) that gait variability increases with 
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disability in MS
12
. That study demonstrated that persons with MS with walking impairment 
(EDSS>4.0) had greater variability of stride length compared to healthy controls, but individuals 
without walking impairment (EDSS≤4.0) did not12.  
 
Gait variability (i.e. fluctuations in gait parameters between steps) is predictive of mobility 
impairment and falls in older adults and other neurological populations
13-15
. Further, movement 
variability is a marker of motor control function and is potentially more sensitive to dysfunction 
than average parameters
16
. Consequently, documentation of gait variability as a function of 
disability is a first step towards investigating the clinical relevance of gait variability in MS. 
 
In this investigation, we examined differences in variability of spatiotemporal gait parameters 
between persons with MS and healthy controls as well as associations between gait variability 
and disability level in persons with MS. We hypothesize that gait variability would be elevated in 
persons with MS compared to controls. Secondly, we hypothesize that gait variability would be 
positively correlated with disability in MS, as indexed by the EDSS. 
 
2.3 Methods 
 
The procedures for this investigation were approved by the local Institutional Review Board and 
all participants provided informed consent prior to data collection.  
 
Persons with and without MS participated in this investigation. Inclusion criteria for participants 
with MS required a neurologist-confirmed diagnosis, the ability to walk without or with an 
11 
 
assistive device (e.g. a cane or walker) and be relapse-free for at least 30 days prior to testing. 
Inclusion criteria for controls required no gait impairment, no assistive device use, and no 
medical condition such as neurological or cardiovascular disease. Upon arrival at the testing 
facility, participants with MS underwent an examination by a neurologist to generate an EDSS 
score
2
.  
 
To determine variability in spatiotemporal gait parameters, all participants performed two 
walking trials across a 7.9 meter GAITRite
TM
 (CIR Systems Inc., Haverton, PA, USA) electronic 
walkway at self-selected, comfortable speed. Variability of step length, step width, and step time 
were indexed by the coefficient of variation (CV).  The CV of each parameter was calculated 
individually for each pass over the GAITRite
TM
; those values were then averaged within a 
participant to produce an overall CV for each parameter. 
 
Statistical analyses were performed using SPSS software version 19.0 (SPSS Inc., Chicago, IL, 
USA). An independent samples t-test was used to determine group differences between MS and 
controls in age and gait variability, while a Mann-Whitney U test determined group differences 
in gender distribution. Spearman correlations were performed between gait variability, EDSS, 
and age. Partial correlations were performed between gait variability and EDSS while controlling 
for age. Significance was assumed for p<0.05. 
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2.4 Results 
 
Eighty-eight participants with MS and 20 healthy controls participated in this investigation 
(Table 2.1). There were no differences between groups in age or gender distribution (p>0.05). 
The MS group had an average age of 52.4 years, average duration of MS of 11.8 years, and 
median EDSS score of 4.5. Furthermore, 83% of the MS group was female, 32% used unilateral 
assistive devices, and 6% used bilateral assistive devices. The control group had an average age 
of 50.9 years and 80% of the group was female. None of the control group utilized an assistive 
device for walking. 
 
Step length and step time variability were significantly greater in MS versus controls (p<0.001). 
However, there was no significant difference in step width variability between MS and controls 
(Table 2.2). The MS group exhibited average step length variability of 5.1%, step time variability 
of 4.7%, and step width variability of 19.2%. The control group demonstrated step length 
variability of 2.0%, step time variability of 1.8%, and step width variability of 18.5%.  
 
EDSS was significantly correlated to step length variability (ρ=0.57, p<0.001), step time 
variability (ρ=0.40, p<0.001), and step width variability (ρ=-0.35, p=0.001) in MS (Table 2.3). 
Age was significantly correlated to step length variability (ρ=0.37, p<0.001) and step time 
variability (ρ=0.22, p=0.04), but not step width variability (p>0.05). Given that age was related 
to gait variability in our sample and that gait variability has been previously associated with 
advanced aging
10
, we examined correlations between gait variability and EDSS while controlling 
13 
 
for age. While controlling for age, EDSS remained significantly correlated to all three CV 
parameters (rp ranging -0.26 to 0.42, p ranging <0.001 to 0.014).  
 
2.5 Discussion 
 
People with MS have gait impairment
1-10
. Gait impairment in MS has been quantified by mean 
spatiotemporal gait parameters, but less so by variability in those parameters. There is limited 
documentation of gait variability in MS
7,12,13,23
. This investigation examined differences in gait 
variability between a larger group of persons with MS, including a wide range of disability 
levels, and healthy controls. Additionally, we expanded on previous reports by examining the 
correlation between disability (EDSS) and gait variability in ambulatory persons with MS who 
had a wide range of disability status. The major findings of this study were: (1) persons with MS 
have greater variability of step length and step time than healthy controls, (2) variability of step 
length and step time had a significant positive association with disability status, and (3) step 
width variability had a significant negative association with disability status in MS. 
 
The first observation in this investigation was that the MS group had significantly greater 
variability of step length and step time than the healthy control group (Table 2.2). Previous 
work
7
 showed significantly greater variability (CV) of step time in persons with MS with 
minimal disability versus controls, but no difference in variability of step length or step width. 
Another study reported differences in step length between persons with MS with minimal 
disability and controls
8
. Others
12
 report increased stride length variability (CV) in persons with 
MS with EDSS>4.0 than healthy controls, but no difference in step width variability. Our results 
14 
 
are congruent with both [7] and [12] in that we found no difference between MS and controls in 
step width variability. Concerning step time variability, our results are congruent with [7], who 
also reported greater CV of step time in MS versus controls. Our assertion that step length 
variability is greater in MS versus controls is congruent with [8], however [7] reports no 
differences in step/stride length. The difference in observations is possibly due to the inclusion of 
individuals with greater disability in our sample. We have shown that step length variability 
correlates positively with EDSS, therefore the presence of individuals with EDSS>4.0 could 
explain the greater variability of step length in our MS sample. Increased variability of step 
length in persons with MS with greater disability is consistent with [12], who reported a 
difference in stride length CV between persons with MS with EDSS>4.0 and controls, but no 
difference in persons with MS with EDSS<4.0 and controls.  
 
A novel observation of this investigation is that variability of step length and step time correlated 
positively with disability in MS; i.e. persons with greater disability exhibit greater step length 
variability and step time variability (Table 2.3). These associations remained significant when 
controlling for age, confirming that the change in variability in persons with MS is indeed 
associated with disability, and not age per se.  
 
Previous work demonstrated that persons with mild disability with MS had higher gait variability 
(CV of step time and single support time) than age and gender matched controls
7
. The CV values 
in [7], which considered only persons with MS with minimal gait impairment, were 2.8, 2.6, and 
21.8 % for step length CV, step time CV, and base of support CV, respectively. Although these 
values are lower than the results of the current investigation (Table 2.2), the difference most 
15 
 
likely arises from greater average EDSS in our sample (Table 2.1). Additionally, in an 
investigation of gait variability in elderly people, others
13
 reported step length, time, and width 
CV’s that were similar to the values reported in this study, including the greater amplitude of 
step width variability.  
 
There are several possible explanations why step length and step time variability are related to 
disability in persons with MS. Recently, it has been demonstrated that muscle quality (ratio of 
muscle strength to lean muscle mass, i.e. functional muscle strength) is associated with gait 
variability in healthy older adults
20
. Given that persons with MS have decreased muscle strength 
and that muscle strength is related to gait impairment
18
, declines in muscle strength and/or 
muscle quality as a function of disability may contribute to gait variability in MS. Another 
potential explanation for the increase in gait variability in more disabled individuals is an 
increase in noise in the neuromuscular system. This is based on models that demonstrate an 
increase in neuromuscular noise leads to increased gait variability
21
. If elevated neuronal damage 
due to MS in more disabled individuals results in increased neuromuscular noise, this may be 
associated with increased gait variability in those individuals. Lastly, depression contributes to 
increased gait variability in Parkinson’s disease13. Given that depression in MS increases with 
disability
22
, it could also be a contributor to increased gait variability in more disabled 
individuals with MS. Future work needs to examine muscle strength, neuromuscular noise, 
depression, and other potential factors that could drive gait variability in persons with MS. 
 
In contrast to step length and step time variability, step width variability was negatively related 
to disability level (Table 2.3). A possible explanation for decreased step width variability in more 
16 
 
disabled individuals is their use of assistive devices, i.e. canes and walkers. One report asserts 
that the use of a cane leads to significant gait improvement within an individual in persons with 
MS, including reduction in stride and swing time CV
23
. [23] did not report on step width 
variability, though it may also be impacted by assistive device use. In our study, 37.5% of 
participants used an assistive device, with 5.7% using bilateral support (e.g. walkers) (Table 2.1). 
Use of these assistive devices, especially walkers, considering the potential limitations they put 
on mediolateral motion, could explain reduced step width variability in individuals with MS with 
greater disability. Another possible explanation is that since individuals with greater disability 
had greater average step width, they are closer to their stability boundary in the mediolateral 
direction, limiting their potential range of motion in that direction and reducing step width 
variability. 
 
Our results highlight differences between the association of step length and step time variability 
and disability compared to step width variability and disability in persons with MS. Step length 
and step time variability increased with disability, while step width variability decreased as a 
function of disability. Additionally, there is a difference in magnitude between step time and 
length CV and step width CV. Step width CV was ~20% for persons with MS while step length 
CV and step time CV values were ~5%. The 4-fold increase in magnitude of step width 
variability suggests that the mediolateral plane is less tightly controlled than other parameters, 
which has been demonstrated in postural control literature
24
. A potential explanation for these 
observations is the possibility that mediolateral and anterior-posterior plane gait parameters are 
controlled by different neural pathways that could be differently influenced by disability
25,26
. 
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The clinical significance of gait variability in MS is unclear. Gait variability has been associated 
with fall risk in other clinical populations
13-14
.  Previous research
13 
showed that altered step width 
variability is related to falls history in the elderly. Given that one of the factors contributing to 
falls in MS is disability
27,28
 and that the current results demonstrate an association between step 
width variability and disability, it is possible that gait variability may be connected to falls in 
persons with MS. Associations between gait variability and falls in persons with MS warrant 
further investigation.  
 
A potential limitation of this investigation is its cross-sectional nature. Intra-individual changes 
in gait variability were not recorded as disability changed in a given individual over time. A 
second potential limitation was the relatively small number of steps collected to determine gait 
variability. Previous research has reported on variability of spatiotemporal parameters over 
similar time series
11,22
, however some research has suggested that a greater number of steps are 
needed to investigate gait variability in certain situations
29
. Further research is warranted to 
investigate thresholds for reliable studies on gait variability in persons with MS. 
 
In summary, results of the current investigation illustrate that persons with MS have greater 
variability of step length and step time than individuals without MS. Additionally, step length 
and step time variability correlate positively with disability while step width variability correlates 
negatively with EDSS. Potential reasons for altered gait variability in MS include declines in 
muscle strength and muscle quality as well as the influence of depression, assistive device use, 
and the impact of a mediolateral stability boundary on gait variability. Future investigations into 
the contributing factors and consequences of gait variability in MS are warranted. 
18 
 
2.6 References 
 
[1] Pearson OR, Busse ME, Van Deursen RWM, Wiles CM. (2004) Quantification of  
walking mobility in neurological disorders. QJM, 97: 463-475. 
[2] Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis: an expanded  
disability status scale (EDSS). Neurology¸33(11): 1444-1452. 
[3] Larocca NG. (2011) Impact of walking impairment in multiple sclerosis: perspectives of  
patients and care partners. Patient, 4(3): 189-201. 
[4] Benedetti MG, Piperno R, Simoncini L, Bonato P, Tonini A, Giannini S. (1999) Gait  
abnormalities in minimally impaired multiple sclerosis patients. Mult Scler, 5 (5): 
363-8. 
[5] Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E, Galea  
MP. (2006) Gait and balance impairment in early multiple sclerosis in the absence 
of clinical disability. Mult Scler, 12 (5): 620-628. 
[6] Givon U, Zeilig G, Achiron A. (2009) Gait analysis in multiple sclerosis: characterization  
of temporal-spatial parameters using GAITRite functional ambulation system. 
Gait Posture, 29 (1): 138-142. 
[7] Sosnoff JJ, Sandroff BM, Motl RW. (2012) Quantifying Gait Abnormalities in Persons  
with Multiple Sclerosis with Minimal Disability. Gait Posture, epub:  
http://dx.doi.org/10.1016/j.gaitpost.2011.11.027. 
[8] Flegel M, Knox K, Nickel D. (2012) Step-Length Variability in Minimally Disabled  
Women with Multiple Sclerosis or Clinically Isolated Syndrome. Int J MS Care, 
14: 26-30. 
[9] Kalron A, Achiron A, Dvir Z. (2011) Muscular and gait abnormalities in persons with  
early onset multiple sclerosis. J Neurol Phys Ther, 35(4): 164-169. 
[10] Kelleher KJ, Spence W, Solomonidis S, Apatsidis D. (2010) The characterisation of gait  
patterns of people with multiple sclerosis. Disab Rehab, 32 (15): 1242-1250. 
[11] Crenshaw SJ, Royer TD, Richards JG, Hudson DJ. (2006) Gait variability in people with  
multiple sclerosis. Multiple Sclerosis, 12: 613-619. 
[12] Kaipust JP, Huisinga JM, Filipi M, Stergiou N. (2012) Gait Variability Measures Reveal  
Differences between Multiple Sclerosis Patients and Healthy Controls. Motor  
Control, in press.   
[13] Brach JS, Berlin JE, VanSwearingen JM, Newman AB, Studenski SA. (2005) Too much  
or too little step width variability is associated with a fall history in older persons 
who walk at or near normal gait speed. J NeuroEngineering Rehabil, 2: 21, epub.  
[14] Hausdorff JM, Peng CK, Goldberger AL, Stoll AL. (2004) Gait unsteadiness and fall risk  
in two affective disorders: a preliminary study. BMC Psychiatry, 4: 39, epub.  
[15] Lord S, Baker K, Nieuwboer A, Burn D, Rochester L. (2011) Gait variability in  
Parkinson’s disease: an indicator of non-dopaminergic contributors to gait 
dysfunction? J Neurol, 258: 566-572. 
[16] Newell KM, Corcos DM. Issues in variability and motor control. In: Newell KM, Corcos  
DM, editors. Variability and motor control. Champaign, IL: Human Kinetics 
Publishers: 1993: p. 1-12. 
[17] Sosnoff JJ, Gappmaier E, Frame A, Motl RW. (2011) Influence of spasticity on mobility  
and balance in persons with multiple sclerosis. J Neurol Phys Ther, 35 (3): 129-
132. 
19 
 
[18] Thoumie P, Lamotte D, Cantalloube S, Faucher M, Amarenco G. (2005) Motor  
determinants of gait in 100 ambulatory patients with multiple sclerosis. Mult 
Scler, 11: 485-491. 
[19] Sacco R, Bussman R, Oesch P, Kesselring J, Beer S. (2011) Assessment of gait  
parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial. 
J Neurol, 258(5): 889-894. 
[20] Shin S, Valentine RJ, Evans EM, Sosnoff JJ. (2012) Lower extremity muscle quality and  
gait variability in older adults. Age Aging, in press. 
[21] Roos PE, Dingwell JB. (2010) Influence of simulated neuromuscular noise on movement  
variability and fall risk in a 3D dynamic walking model. J Biomech¸43(15): epub. 
[22] Anhoque CF, Dominques SC, Carvalho T, Teixeira AL, Dominques RB. (2011) Anxiety  
and depressive symptoms in clinically isolated syndrome and multiple sclerosis. 
Arg Neuropsiquiatr, 69 (6): 882-886. 
[23] Gianfrancesco MA, Triche EW, Fawcett JA, Labas MP, Patterson TS, Lo AC. (2011)  
Speed- and cane-related alterations in gait parameters in individuals with multiple 
sclerosis. Gait Posture, 33: 140-142. 
[24] O’Connor SM, Kuo AD. (2009) Direction-dependent control of balance during walking  
and standing. J NEurophisiol, 102 (3): 1411-19. 
[25] Al-Yahya E, Dawes H, Smith L, Dennis A, Howells K, Cockburn J. (2011) Cognitive  
motor interference while walking: A systematic review and meta-analysis. 
Neurosci Biobehav Rev, 35: 715-728. 
[26] Moe-Nilssen R, Aaslund MK, Hodt-Billington C, Helbostad JL. (2010) Gait variability  
measures may represent different constructs. Gait Posture, 32: 98-101. 
[27] Finlayson ML, Peterson EW, Cho CC. (2006) Risk factors for falling among people aged  
45 to 90 years with multiple sclerosis. Arch Phys Med Rehabil, 87: 1274-1279. 
[28] Sosnoff JJ, Socie MJ, Boes MK, Sandroff BM, Pula JH, Suh Y, Weikert M, Balantrapu  
S, Morrison S, Motl RW. (2011) Mobility, balance and falls in persons with 
multiple sclerosis. PLoS One, 6(11): e28021. 
[29] Hollman JH, Childs KB, McNeil ML, Mueller AC, Quilter CM, Youdas JW. (2010)  
Number of strides required for reliable measurements of pace, rhythm and 
variability parameters of gait during normal and dual talk walking in older 
individuals. Gait Posture, 32: 23-28. 
 
 
 
  
20 
 
2.7 Tables 
 
Table 2.1. Baseline characteristics for MS and control groups are reported. The MS and control 
groups were not significantly different in age or gender composition. 
 MS 
(N=88) 
Controls 
(N=20) 
Age 
[years] 
Mean 
(SD) 
Range 
52.4 
(11.1) 
30-78 
50.9 
(8.7) 
31-62 
MS duration 
[years] 
11.8 
(9.9) 
0-43 
N/A 
EDSS 
[-] 
Mean 
(IQR) 
Range 
4.5 
(3.0) 
2.0-6.5 
N/A 
Gender 
[% female] 
 
 
83.0 
 
80.0 
 
Unilateral assist 
[% users] 
31.8 
 
0.0 
 
Bilateral assist 
[% users] 
5.7 
 
0.0 
 
 
Table 2.2. Coefficient of variation of spatiotemporal gait parameters is reported (standard 
deviation) for MS and control groups. The p-value reflects the statistical difference between 
groups from an independent samples t-test. Significance was assumed for p<0.05. 
 MS Control p 
Step length CV 
[%] 
5.1
 
(2.7) 
2.0 
(0.8) 
<0.001 
Step time CV 
[%] 
4.7
 
(2.4) 
1.8 
(0.5) 
<0.001 
Step width CV 
[%] 
19.2
 
(11.9) 
18.5 
(5.2) 
0.803 
 
Table 2.3. Spearman-rho correlation results between EDSS, age, and CV of step length, step 
time, and step width in the MS group are reported. Partial correlations between EDSS and CV 
parameters while controlling for age are also reported. 
 Spearman-rho Partial 
EDSS Age EDSS 
ρ p 
(2-tailed) 
ρ p 
(2-tailed) 
ρ p 
(2-tailed) 
Age .440 <0.001 - - - - 
Step length CV .572 <0.001 .374 <0.001 .421 <0.001 
Step time CV .401 <0.001 .219 0.040 .339 0.001 
Step width CV -.350 0.001 -.066 0.543 -.263 0.014 
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CHAPTER 3 
 
 
 
VARIABILITY OF LOWER-LIMB JOINT AND SEGMENT ANGLES IN MS GAIT 
 
 
 
3.1 Abstract 
 
Multiple sclerosis (MS) is a neurological disease that often results in gait impairment. It has been 
suggested that gait variability, i.e. fluctuations between steps during walking, is potentially more 
sensitive to dysfunction than average gait parameters. However, gait variability in MS has not 
been documented thoroughly. In this investigation, 14 individuals with MS and 10 controls 
walked at 75%, 100%, and 125% of their preferred walking speed on a treadmill. Gait variability 
was quantified by standard deviation of lower-limb joint and segment angles as well as by phase 
portrait (segment angle versus angular velocity) analysis. Persons with MS exhibited a 
significant change in variability of the ankle joint and thigh segment as walking speed increased. 
The control group exhibited greater variability of the foot segment than the MS group, which 
was surprising given previous documentation of increased gait variability in MS compared to 
controls. Future research is needed to adequately document differences between persons with 
MS and controls in kinematic gait variability as well as to understand the underlying factors that 
drive gait variability and changes in gait variability due to walking speed in MS. 
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3.2 Introduction  
 
Multiple sclerosis (MS) is an autoimmune disease that results in damage to the central nervous 
system. In MS, myelin is destroyed, resulting in damage to axons, distortion of signal 
transduction, and formation of scar tissue. MS affects approximately 400,000 Americans and 
more than 2 million people world-wide. The disease is 2-3 times more prevalent in women than 
men and is typically diagnosed between the ages of 20-50
1
. MS has a variety of symptoms 
including gait impairment, commonly considered the most impactful aspect of the disease
2
.   
 
Gait impairment in MS has been well documented and is reflected in changes to spatiotemporal 
gait parameters as well as gait kinematics. Individuals with MS have been shown to walk slower, 
with reduced step/stride length and cadence, and increased time in the double-support phase of 
the gait cycle
3-7
. Persons with MS also exhibit altered lower-limb kinematic patterns than healthy 
individuals.  Persons with MS have been shown to have different angular positioning of the 
lower limbs at heel strike and toe off and reduced range of motion during ambulation compared 
to healthy controls
5-7
.  
 
In addition to changes in the values of spatiotemporal and kinematic gait parameters in persons 
with MS, it has been demonstrated that persons with MS exhibit greater gait variability than 
healthy individuals. Gait variability refers to fluctuations in gait parameters between steps during 
ambulation. Previous reports demonstrated that persons with MS with minimal disability have 
larger variability of step and single-support time
8
 and step length
9
 than individuals without MS. 
One study reported a greater standard deviation of ankle, knee, and hip angles in persons with 
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MS compared to healthy controls
10
. Overall, however, there is limited documentation of 
variability of gait kinematics in persons with MS. 
 
Once dismissed as simply signal noise, there has been increasing research exploring the meaning 
and clinical implications of physiological signal variability. It has been suggested that gait 
variability is potentially more sensitive to dysfunction than mean parameters due to connections 
between variability and motor control function
11
.  Gait variability has been associated with falls 
in elderly individuals and other populations with neurological deficits
12-14
. Others have looked at 
gait variability as a way of examining the impact of injuries and compensation injuries
15
 as well 
as a way to monitor injury recovery
16
.  
 
The purpose of this investigation was to examine changes in variability of lower-limb joint and 
segment angles in persons with MS compared to healthy controls. 
 
3.3 Methods 
 
Inclusion criteria for the MS group included a diagnosis of MS, age 18-64, and the ability to 
walk on a treadmill for 2 minutes. Healthy control subjects also participated and were screened 
for neurological disease, orthopedic surgery or other major lower limb injuries, and major 
cardiac problems. Procedures for this investigation were approved by the local Institutional 
Review Board. 
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After consenting to the study, participants completed 3 walking trials on a treadmill at various 
speeds.  Prior to the first trial, the participants provided feedback to a researcher who adjusted 
the treadmill speed to the participant’s comfortable walking pace.  The first trial was then 
collected at that self-selected speed, followed by trials of 125% and 75% of the self-selected 
speed. The order of the “fast” and “slow” trials was randomized.  Trials were 30 seconds long.  
Participants were permitted to use handrails of the treadmill (directly in front of them) during the 
trials if they so desired, but no assistive devices. Multiple walking speeds were recorded in order 
to examine the impact of changing speeds on gait variability. It has been demonstrated in healthy 
young individuals that magnitude of gait variability decreases as walking speed increases from 
80-120% of an individual’s comfortable walking speed17.  
 
Kinematic data were collected at 100 Hz using a 9-camera motion capture system including 
Eagle Digital Cameras and Cortex 1.14 software (MotionAnalysis Co., Santa Rosa, CA, USA).  
Participants were outfitted with reflective markers that were placed on their right side, located at 
the anterior superior iliac spine (hip), femoral lateral epicondyle (knee), lateral maleolus (ankle), 
calcaneus (heel), and 1
st
 metatarsal head (toe).  Using these markers, five sagittal plane segment 
and joint angles were defined: the thigh, shank, foot, knee, and ankle. Marker data were filtered 
with a low-pass Butterworth filter at a cutoff frequency of 10 Hz prior to data analysis. 
 
Variability of joint and segment angles was quantified by the average standard deviation across 
the gait cycle, which was calculated by averaging the standard deviation across all strides at 1% 
increments of the gait cycle
10
. Segment variability was indexed additionally using a method to 
quantify cycle-to-cycle gait variability based on segment angle phase portraits
15
 (segment angle 
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versus angular velocity). In segment phase portraits (Figure 3.1), the centroid of the shape 
created by each individual gait cycle was calculated; variability was quantified by the motion of 
that centroid point between consecutive gait cycles. Centroid motion was quantified by two 
metrics that arise from posturography: (1) 95% confidence ellipses for the area encompassing 
centroid points, and (2) the summation of the distance between consecutive centroid points (i.e. 
centroid path length). For this investigation, the path length was normalized by the number of 
gait cycles taken by each participant. To include as much data as possible for analysis, we chose 
to include as many gait clcyes as possible for each individual and then normalize the path length 
results by that number of gait cycles. This is different from the original method in [15], in which 
the same number of gait cycles was analyzed for each participant. 
 
Statistical analysis of results was performed using SPSS 19.0 software (SPSS Inc., Chicago, IL, 
USA). Differences in age, and average walking speed between the MS and control groups were 
analyzed using an independent samples t-test. Differences between groups in gender distribution 
were analyzed using a Mann-Whitney U test. Gait variability metrics were placed into a mixed-
model repeated measures ANOVA with group (MS vs. control) as the between subjects factor 
and speed as the within subjects factor. Significance was assumed for p<0.05. 
 
3.4 Results 
 
Fourteen persons with MS (age 46.1 ± 10.8, 11 female / 3 male) and 10 healthy controls (age 
50.6 ± 12.0, 8 female / 2 male) participated in this investigation. The average walking speeds and 
number of steps taken at each walking speed by the MS and control groups were not statistically 
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different (Table 3.1). Additionally, there were no differences between the MS and control groups 
in age and gender composition (p>0.05).  
 
Table 3.2 reports standard deviations of ankle, knee, thigh, shank, and foot angles for MS and 
controls and the results of repeated measures analysis on those parameters. MS and controls both 
displayed significant change in ankle angle standard deviation due to speed (p=0.007 for MS, 
p=0.042 for controls). Additionally, the control group had a significant speed effect on knee 
(p=0.037) and foot angle (p=0.026). There was no significant difference between groups for 
standard deviation of any joint or segment angle, nor any significant group by speed interaction 
(p>0.05). 
 
Table 3.3 reports segment variability, quantified by the motion of centroids of the shapes 
produced by each gait cycle in segment angle phase portraits. Five out of 14 participants with 
MS demonstrated an outlying value for at least one metric of phase portrait variability. Outlying 
values were removed from analysis. There was no significant speed, group, or group by speed 
interaction effect in centroid path length for the thigh, shank, or foot segment (p>0.05). 95% 
confidence ellipse results suggested that the MS group had significantly lower variability of the 
foot than healthy controls (p=0.020). Additionally, the MS group demonstrated a significant 
speed effect for thigh variability (p=0.037), also indexed by the 95% confidence ellipse for 
centroid motion.  
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3.5 Discussion 
 
The objective of this study was to examine differences in kinematic gait variability between 
persons with MS and healthy controls over a range of walking speeds. A major finding of this 
investigation was that the MS group demonstrated a significant effect of speed on gait variability 
at the ankle joint (indexed by standard deviation) and at the thigh segment (indexed by 95% 
confidence ellipse in phase portrait analysis) (Table 3.2). Increasing walking speed caused 
individuals with MS to exhibit decreased standard deviation of ankle angle, which was a pattern 
that was similar to the control group in this study and has basis in previous research. Gait 
variability has been found to decrease in magnitude (coefficient of variation) as a result of 
increasing gait speed in healthy individuals
17
. The observation that gait variability significantly 
changed as a function of walking speed is important for future research on gait variability in MS. 
Future studies on gait variability in MS should document walking speed and should consider the 
potential impact of preferred walking speed on gait variability in their observations. 
 
Concerning variability of leg segment angular movements, there were limited differences 
between MS and controls. There were no significant differences between MS and controls in 
standard deviation of the angular motion of the thigh, shank, or foot (Table 3.2). However, phase 
portrait analysis yielded a significant difference between the MS and control groups for motion 
of the foot segment (Table 3.3). The MS group had significantly lower variability of foot motion 
as indexed by the 95% confidence ellipse than the control group (p=0.02). Lower movement 
variability at the foot is a surprising result, given that previous reports have only documented 
greater gait variability in MS compared to controls
8-10,18
. One potential explanation for the lower 
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variability at the foot in MS versus controls could be reduced range of motion at the ankle, which 
has been demonstrated previously in MS
5
.  
 
It is possible that standard deviations and phase portrait metrics measure different aspects of gait 
variability. This is evidenced by finding reduced variability of foot motion in the MS group 
through phase portrait analysis while there was no difference in standard deviation of foot angle. 
Also, standard deviation was sensitive to changes in speed in MS while no phase portrait metrics 
had a significant speed effect. An explanation for the discrepancy may be that phase portrait 
analysis truly measures cycle-to-cycle variability in that each gait cycle is reduced to one 
centroid point and variability is quantified by only those 15-25 centroid points. Standard 
deviation analysis took into consideration the average standard deviation across all 100 points of 
each gait cycle as well as the average across the total number of cycles. In that way, standard 
deviation analysis is more of a combination of within-stride and between-stride variability while 
phase portrait variability is purely between-stride. 
 
Overall, we detected few differences in gait variability between MS and controls. This was 
unexpected given that previous research reported elevated variability of spatiotemporal 
parameters
8,9,18
 in persons with MS. It was particularly surprising that we found no difference 
between MS and controls in standard deviation of knee and ankle angles because it has been 
reported in previous literature
10
. Comparison of our results to [10] reveals that we report very 
similar values for knee and ankle standard deviation in MS. We report standard deviations of 2.7 
± 2.1 degrees at the knee and 1.4 ± 0.7 degrees at the ankle in our MS group at comfortable pace. 
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These values are very close to the standard deviation values in MS in [10] of 2.7 ± 0.8 degrees at 
the knee and 1.5 ± 0.4 degrees at the ankle.  
 
There are several possible explanations for the differences in our results concerning knee and 
ankle standard deviation compared to [10]. First of all, we reported greater variability within our 
group than [10], which could result in less statistical difference between our MS and control 
groups. Second, although both reports use the same method for reporting joint angle standard 
deviation, there were other methodological differences. Our study measured variability during 
walking on a treadmill while [10] determined gait variability from non-consecutive over-ground 
strides. The presence of the treadmill itself, including hand rails, and the differences between a 
moving belt and over ground walking can cause changes in gait
19
. A third possible difference 
between our study and [10] was the walking speed of the participants. The MS group in our 
study walked at the same self-selected speed as the control group. Walking speed was not 
reported in [10], but it is expected that their MS group walked at a slower speed than their 
control group
3,4,6,7
, which could have contributed to the group differences they report in gait 
variability. Given that we have shown significant changes in gait variability due to walking 
speed in MS, future studies should consider the potential influence of walking speed on their 
research question. A future, potentially larger study should re-examine differences between MS 
and controls in joint angle standard deviation and other gait variability metrics.  
 
Surprisingly, the MS and control groups did not differ significantly in walking speed or number 
of steps in each 30 second trial. This result is surprising because it is well established that people 
with MS walk with reduced velocity and cadence
3,4,6,7
. A possible explanation for the lack of 
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differences in velocity is the presence of the treadmill itself. Participants in the MS group were 
allowed to use the handrails of the treadmill, which could have allowed them to feel comfortable 
walking a higher speed. No control participant used the handrails, so there was no impact of 
additional stability on the control group. 
 
There were limitations of this investigation. The biggest limitation was the small sample size 
(N=14 with MS, 10 controls). Statistical significance may be over or under-estimated in analyses 
with small sample sizes and statistical power of current observations is low. Second, walking 
trials were performed on a treadmill, which can cause alterations from a person’s normal over-
ground gait
19
. Third, gait trials were limited to 30 seconds, limiting the number of gait cycles 
available for variability analysis. It has been suggested that a greater number of strides should be 
collected to accurately measure gait variability
20
, although other publications have documented 
gait variability using similar timescales to this investigation. 
 
Looking forward, the results of this investigation should caution future researchers to fully 
consider the effects of their methodology on preferred walking speed, which affects gait 
variability. Varying results between phase portrait analysis and standard deviation analysis of 
lower-limb segment motion suggests that phase portrait analysis and traditional metrics are 
sensitive to different things. Concerning variability of joint motion, future work is warranted to 
clarify potential differences between persons with MS and healthy controls for standard 
deviation of lower limb joint angles. Future examination of the factors driving gait variability 
and changes in gait variability due to speed in MS is warranted. 
 
  
31 
 
3.6 References 
 
[1] National Multiple Sclerosis Society website. About MS. Available at:  
http://www.nationalmssociety.org/about-multiple-sclerosis/index.aspx.  Accessed 
January 23, 2012. 
[2] Larocca NG. (2011) Impact of walking impairment in multiple sclerosis: perspectives of  
patients and care partners. Patient, 4(3): 189-201. 
[3] Sosnoff JJ, Weikert M, Dlugonski D, Smith DC, Motl RW (2011) Quantifying gait  
impairment in multiple sclerosis using GAITRite
TM
 technology. Gait Posture, 34 
(1): 145-147. 
[4] Givon U, Zeilig G, Achiron A (2009) Gait analysis in multiple sclerosis: Characterization  
of temporal-spatial parameters using GAITRite functional ambulation system. 
Gait Posture, 29: 138-142. 
[5] Kelleher KJ, Spence W, Solomonidis S, Apatsidis D (2010) The characterisation of gait  
patterns of people with multiple sclerosis. Disabil Rehabil, 32 (15): 1242-1250. 
[6] Martin CL, Phillips BA, Kilpatrick TJ, Butzkueven H, Tubridy N, McDonald E, Galea  
MP (2006) Gait and balance impairment in early multiple sclerosis in the absence 
of clinical disability. Multiple Sclerosis¸12: 620-628. 
[7] Benedetti MG, Piperno R, Simoncini L, Bonato P, Tonini A, Giannini S (1999) Gait  
abnormalities in minimally impaired multiple sclerosis patients. Multiple 
Sclerosis, 5: 363-368. 
[8] Sosnoff JJ, Sandroff BM, Motl RW. (2011) Quantifying Gait Abnormalities in Persons  
with Multiple Sclerosis with Minimal Disability. Gait Posture, in press. 
[9] Flegel M, Knox K, Nickel D. (2012) Step-Length Variability in Minimally Disabled  
Women with Multiple Sclerosis or Clinically Isolated Syndrome. Int J MS Care, 
14: 26-30. 
[10] Crenshaw SJ, Royer TD, Richards JG, Hudson DJ. (2006) Gait variability in people with  
multiple sclerosis. Multiple Sclerosis, 12: 613-619. 
[11] Chau T, Young S, Redekop S. (2005) Managing variability in the summary and  
comparison of gait data. J NeuroEng Rehabil, 2: 22. doi: 10.1186/1743-0003-2-
22. 
[12] Brach JS, Berlin JE, VanSwearingen JM, Newman AB, Studenski SA. (2005) Too much  
or too little step width variability is associated with a fall history in older persons 
who walk at or near normal gait speed. J NeuroEngineering Rehabil, 2: 21, epub.  
[13] Lord S, Baker K, Nieuwboer A, Burn D, Rochester L. (2011) Gait variability in  
Parkinson’s disease: an indicator of non-dopaminergic contributors to gait 
dysfunction? J Neurol, 258: 566-572. 
 [14] Hausdorff JM, Rios DA, Edelberg HK. (2001) Gait Variability and Fall Risk in  
Community-Living Older Adults: A 1-Year Prospective Study. Arch Phys Med 
Rehab, 82: 1050-1056. 
[15] DiBerardino III LA, Polk JD, Rosengren KS, Spencer-Smith JB, Hsiao-Wecksler ET  
(2010) Quantifying complexity and variability in phase portraits of gait. Clinical 
Biomech, 25: 552-556. 
[16] Moraiti C, Stergiou N, Ristanis S, Georgoulis AD. (2007) ACL deficiency affects stride- 
to-stride variability as measured using nonlinear methodology. Knee Surg Sports 
Traumatol Arthorsc¸15: 1406-1413. 
32 
 
[17] Jordan K, Challis JH, Newell KM. (2007) Walking speed influences on gait cycle  
variability.Gait Posture, 26: 128-134. 
[18] Socie MJ. (2012) Gait variability and disability in multiple sclerosis. Thesis chapter 2. 
[19] Powell W, Stevens B, Simmonds M. (2009) Treadmill Interface for Virtual Reality vs  
Over ground Walking: A comparison of gait in individuals with and without pain. 
Stud Health Technol Inform, 144: 198-203. 
[20] Hollman JH, Childs KB, McNeil ML, Mueller AC, Quilter CM, Youdas JW. (2010)  
Number of strides required for reliable measurements of pace, rhythm and 
variability parameters of gait during normal and dual talk walking in older 
individuals. Gait Posture, 32: 23-28. 
 
 
  
33 
 
3.7 Figures 
 
 
Figure 3.1. An example of a shank segment phase portrait. Each gait cycle produces one “loop” 
in the phase portrait, which dictates one centroid point. Gait variability is indexed by 
measurements of the motion of centroid points from cycle to cycle. 
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3.8 Tables 
Table 3.1. Walking speed and the number of steps analyzed at each speed are reported for the 
MS and control groups. Gait was analyzed at 75%, 100%, and 125% of each individual’s self-
selected, comfortable walking speed. There were no significant differences between groups for 
speed or step counts. 
 Walking Speed 
Slow Comfortable Fast 
Treadmill speed 
[km/hr] 
MS 
Controls 
1.3 ± 0.6 
1.5 ± 0.5 
1.8 ± 0.8 
2.0 ± 0.7 
2.2 ± 1.1 
2.5 ± 0.8 
Number of steps 
(right leg) 
MS 
Controls 
19.4 ± 4.1 
22.0 ± 3.8 
22.9 ± 4.5 
26.0 ± 2.4 
24.6 ± 5.3 
28.1 ± 3.4 
 
 
 
Table 3.2. Standard deviations of leg joint and segment angles are reported at each walking 
speed for the MS and control groups. Repeated measures analysis of speed, group, and group by 
speed interactions are also shown, with significance assumed for p<0.05. 
Joint/segment 
angle 
 Standard deviation [degrees] Repeated measures interactions 
[p] 
Slow Comfortable Fast Speed Group Group x Speed 
Ankle MS 
Controls 
2.0 ± 1.2 
1.9 ± 0.8 
1.4 ± 0.7 
1.5 ±0.5  
1.4 ± 0.6 
1.4 ± 0.8 
0.007 
0.042 
0.947 0.841 
Knee MS 
Controls 
3.2 ± 2.6 
2.4 ± 0.8 
2.7 ±2.1 
1.8 ± 0.6 
2.2 ± 1.4 
1.7 ± 0.8 
0.093 
0.037 
0.255 0.747 
Thigh MS 
Controls 
2.3 ± 2.4 
1.5 ± 0.5 
2.2 ± 2.3 
1.2 ± 0.5 
1.8 ± 1.7 
1.2 ± 0.8 
0.251 
0.314 
0.239 0.649 
Shank MS 
Controls 
2.6 ± 2.2 
2.0 ± 0.8 
2.3 ± 2.2 
1.6 ± 0.5 
2.0 ± 1.9  
1.4 ± 0.7 
0.133 
0.053 
0.365 0.948 
Foot MS 
Controls 
2.6 ± 2.4  
2.4 ± 1.0 
2.4 ± 2.6  
1.9 ± 0.6 
2.3 ± 2.1 
1.7 ± 0.7 
0.505 
0.026 
0.593 0.619 
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Table 3.3. Variability of the thigh, shank, and foot segments as deduced from segment angle 
phase portrait analysis is reported. Repeated measures analysis of speed, group, and group by 
speed interactions are also shown, with significance assumed for p<0.05. 
Segment 
 
 Centroid path length / # steps (x10
3
) Repeated measures interactions 
[p] 
Slow Comfortable Fast Speed Group Group x Speed 
Thigh MS 
Controls 
15.5 ± 4.4 
19.5 ± 8.5 
14.6 ± 4.5 
14.8 ± 4.8 
16.6 ± 4.8 
14.7 ± 6.8 
0.594 
0.095 
0.694 0.179 
Shank MS 
Controls 
22.5 ± 11.1 
24.9 ± 10.5 
21.4 ± 14.0 
17.9 ± 5.1 
17.3 ± 4.3 
19.8 ± 12.7 
0.251 
0.199 
0.881 0.369 
Foot MS 
Controls 
19.4 ± 6.3 
29.6 ± 11.1 
20.1 ± 13.7 
20.5 ± 4.5 
17.4 ± 4.7 
24.0 ± 14.8 
0.687 
0.067 
0.095 0.168 
 Centroid 95% ellipse area (x10
3
) Repeated measures interactions 
[p] 
Thigh MS 
Controls 
6.8 ± 3.1 
6.9 ± 3.6 
3.4 ± 1.4 
5.8 ± 6.2 
5.2 ± 2.5 
8.8 ± 14.3 
0.037 
0.645 
0.417 0.613 
Shank MS 
Controls 
10.1 ± 5.8 
19.6 ± 15.9 
9.2 ± 5.0 
12.7 ± 7.2 
8.5 ± 3.0 
10.8 ± 11.7 
0.618 
0.164 
0.090 0.280 
Foot MS 
Controls 
8.2 ± 4.4 
18.9 ± 13.9 
7.4 ± 3.0 
11.0 ± 3.5 
8.7 ± 3.8 
12.9 ± 8.0 
0.640 
0.092 
0.020 0.117 
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CHAPTER 4 
 
 
 
A NOVEL METRIC OF FOOTFALL VARIABILITY AND FALL HISTORY IN MULTIPLE  
 
SCLEROSIS 
 
 
 
4.1 Abstract 
 
Fifty percent of persons with multiple sclerosis (MS) fall in a given year. The purpose of this 
investigation was to determine associations between gait variability, including a new method for 
quantifying footfall placement variability, and fall history in people with MS. 47 individuals with 
MS and 20 healthy controls participated in this investigation. Individuals with MS were placed 
into two groups based on self-report fall history: recurrent (2+ falls in previous year) and non (- 
falls in previous year) fallers. Gait variability was quantified in both MS groups and healthy 
controls in two ways. One method was to calculate the coefficient of variation (CV) of step 
length, step width, and step time. Additionally, footfall variability (FV) was quantified by a 
novel metric that determined the order of Fourier series (i.e. the number of sine and cosine terms) 
necessary to accurately fit a pattern of footfall center of pressure coordinates from a 7.9 meter 
walk. While there were no differences between MS fall groups in traditional variability metrics 
(CV), the recurrent fallers group had significantly greater footfall variability (FV=7.0 ± 1.5) than 
the non fallers with MS (FV=5.8 ± 2.2). The current observations indicate that footfall variability 
is related to fall history in people with MS, but that associations between gait variability and falls 
in MS are not captured by traditional gait variability metrics. However, further investigation to 
evaluate the reliability of this novel method for quantifying footfall variability is warranted. 
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4.2 Introduction 
 
Multiple sclerosis (MS) is an autoimmune disease that causes damage to the central nervous 
system. Symptoms of MS include gait, balance, cognitive, and sensory impairment. Given that 
all of these symptoms have been linked to falls in other clinical populations
1-4
, it is not surprising 
that persons with MS are at elevated risk of falling. Previous research has shown that up to 50% 
of persons with MS report falling over a 6-12 month time period
5-8
. The incidence varies in the 
literature with reports that from 33-79% of fallers with MS are recurrent fallers (2+ falls in the 
previous year)
6,8,9
. Moreover, greater than 50% of falls in persons with MS are injurious
7,10
. 
Consequently, it is paramount to understand factors related to falls in MS so that appropriate 
interventions can be designed and implemented. 
 
A number of factors have been linked to falls in MS including disability status, reduced postural 
control, gait impairment, muscle weakness, and use of assistive devices
5-12
. Clinically, 
performance tests (e.g. Berg Balance Scale, Timed Up and Go, Dynamic Gait Index) and self 
report measures (e.g. Activities-specific Balance Confidence, Dizziness Handicap Inventory, and 
12-item Multiple Sclerosis Walking Scale) have been used to assess walking and balance 
deficiencies and falls in MS
11,13,14
. However, there has been a limited amount of research 
documenting subjective, quantitative measures of walking and balance and their associations 
with falls in MS
6,8
.  
 
One quantitative characteristic of walking behavior that has been found to be related to stability 
and falls in other clinical populations
15-18
 is gait variability. For instance in elderly adults, very 
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high or very low step width variability was associated with falling in the previous year while 
moderate step width variability was not
16
. Additionally, a linear association has been 
demonstrated between variability of step length and double-support phase and incidence of 
multiple falls in the elderly
17
.  Recurrent falls were also associated with variability of gait speed, 
cadence, and step time
17
. However, associations between gait variability and falls in persons with 
MS remain unknown.  
 
People with MS exhibit greater variability of kinematic movement
19
 and spatiotemporal gait 
parameters than healthy controls
20-22
. Gait variability has been documented in MS using mostly 
magnitude metrics such as standard deviation
19,20 
(SD) and coefficient of variation
21,23,24
 (CV). In 
this investigation, a novel method for quantifying gait variability is introduced that examines 
variability of footfall placement during a short walk. Variability of footfall placement is 
potentially more holistic than typical magnitude metrics because it quantifies variability in the 
anterior-posterior (AP) and mediolateral (ML) planes simultaneously. While the method in this 
investigation is novel, footfall placement variability has been studied previously in walking and 
balance analysis of individuals in clinical populations
25
. Previous research found associations 
between variability of footfall location relative to an individual’s center of mass and traditional 
balance tests such as the Berg Balance Scale and Dynamic Gait Index in individuals recovering 
from spinal cord injury
25
. 
 
The purpose of this investigation was to examine associations between fall history and gait 
variability in persons with MS using traditional metrics as well as a novel analysis of footfall 
placement variability. Based on previous reports showing elevated gait variability in MS
19-22
, we 
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hypothesize that persons with MS will demonstrate greater gait variability than controls. We 
further hypothesize that recurrent fallers with MS will exhibit greater gait variability, including 
footfall variability, than non fallers with MS. 
 
4.3 Methods 
 
All individuals provided informed consent prior to participation. Procedures for this investigation 
were approved by the local Institutional Review Board.  
 
Inclusion criteria for participants with MS required a neurologist-confirmed diagnosis of MS, the 
ability to walk (with or without assistive devices), and having been relapse free for 30 days prior 
to testing. Inclusion criteria for healthy controls required no falls in the previous year, 
neurological disease, cardiac problems, or other serious health concerns. Participants with MS 
were placed into two groups based on self-reported fall history: recurrent fallers (2+ falls in the 
previous year) and non fallers (0 falls in the previous year). Participants reporting 1 fall were 
excluded from analysis because of the uncertainty regarding the circumstances of individual 
falls.  
 
Upon arrival, participants with MS underwent examination by a neurologist to determine 
Expanded Disability Status Scale
26
 (EDSS). Then, all participants performed two walking trials 
across a 7.9 meter GAITRite
TM
 electronic walkway (gait mat) at their self-selected comfortable 
speed. Participants walked with shoes on, with or without using assistive devices (e.g. canes, 
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walkers). Walking trials began 1 meter in front of the gait mat and concluded 1 meter behind the 
gait mat in order to measure only steady-state walking. 
 
Gait variability was indexed using two methods: first, the coefficient of variation (CV= standard 
deviation/mean) of step time, step length, and step width was calculated. Second, gait variability 
was indexed by a novel metric that quantified variability of the footfall placement in the AP-ML 
plane.  
 
The footfall pattern from each individual pass over the gait mat was captured by examining the 
coordinates of the center of pressure (COP) during multiple footfalls in a single walk. To 
quantify variability of the footfall placement, the sequence of footfall patterns was fit with a 
Fourier series of sine and cosine waves using MATLAB R2010a (MathWorks, Inc., Natick, MA, 
USA), following the form:  
 
, (4.1) 
 
where y is the COP coordinate in the ML plane, x is the COP coordinate in the AP plane, n is the 
series order, ω is frequency, and Ai, Bi are constants. Beginning with a first order series, each 
footfall sequence was fit with Fourier series of increasing order until the error between the fitted 
curve and the footfall pattern was less than a threshold value (Figures 4.1 – 4.3). Five percent 
error was tolerated because the purpose of this analysis was to analyze overall footfall locations, 
not to model the shape of COP motion within individual footfalls. 
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In this paradigm, footfall variability (FV) is defined as the order of Fourier series required to best 
fit a given footfall sequence. Larger FV values (i.e. number of terms in the series) indicate 
greater variability of footfall placement. FV values range from 1 to 9. An ideal footfall pattern 
(i.e. minimal variability in step length or step width and drift of the center of mass) would result 
in FV=1. However, a certain level of variability is healthy in biological systems
27
 therefore even 
healthy individuals may demonstrate FV values greater than 1. The maximum FV value was 9 
because the Fourier fit function in MATLAB (fit(X,Y,‘fourier’)) has a maximum possible order 
of 8. Therefore, any footfall output that had error greater than the threshold value with an 8
th
 
order series was assigned FV=9. 
 
For each participant, gait variability was quantified for both walks over the gait mat individually. 
Those values were then averaged to produce average CV and FV values for each participant over 
the two trials. These average values were used in statistical analysis. 
 
Statistical analysis was performed with SPSS version 19.0 (SPSS Inc., Chicago, IL, USA). A 
one-way ANOVA was used to assess group differences in gait variability and age between 
recurrent fallers with MS, non fallers with MS, and healthy controls. Subsequently, Least 
Significant Difference post hoc analysis was performed. Group differences in gender distribution 
were assessed by a Kruskal-Wallis test. Significance was assumed for p<0.05. 
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4.4 Results 
 
Forty-seven people with MS participated in this investigation. Six individuals who reported 
falling one time in the previous year were removed from analysis. Twenty-two individuals with 
MS reported falling 0 times in the previous year (average age 51.2) while 19 reported falling two 
or more times in the previous year (average age 54.4). Twenty healthy controls (same control 
group as chapter 2) were also analyzed (average age 50.9). Participant characteristics including 
age, gender, walking speed, and disability status are reported in Table 4.1. There were no 
differences between the three groups in age or gender distribution (p>0.05). The recurrent fallers 
group had significantly greater EDSS (EDSS=4.9) than the non fallers with MS (EDSS=3.9) 
(p=0.034). Non fallers with MS walked at a speed of 1.1 m/sec, which was significantly faster 
than recurrent fallers with MS, who walked at 0.9 m/sec (p=0.018). The control group walked at 
a speed of 1.50 m/sec, which was significantly faster than both MS groups (p≤0.001). 
 
Gait variability, including CV of step width, step length, and step time and footfall variability 
(FV) are reported in Table 4.2 for both MS groups and controls. There were no significant 
differences between MS groups in CV of step width, length, or time (p>0.05). Also, there were 
no differences between MS groups and the control group in step width CV (p>0.05). However, 
both MS fall groups demonstrated greater footfall variability (p<0.001), step length CV 
(p≤0.016), and step time CV (p≤0.006) than the control group. Footfall variability for recurrent 
fallers with MS was FV=7.0 ± 1.6, which was significantly greater (p=0.043) than non fallers 
with MS, who recorded FV=5.8 ± 2.2. Both MS groups had significantly greater FV than 
controls, who recorded FV=1.3 ± 0.5. 
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4.5 Discussion 
 
The most important outcome of this investigation was that footfall variability, quantified using a 
novel methodology, is greater in recurrent fallers with MS compared to non fallers with MS, 
while traditional metrics of gait variability were not able to distinguish any difference. Previous 
reports
16-18
 have found associations between gait variability and falls in the elderly, indexed 
using traditional metrics such as CV of spatiotemporal parameters. However, there were no 
differences between MS fall groups in CV of step length, step time, or step width in the current 
investigation. The lack of differences between fall groups in the current sample based on a 
simple variability metric such as CV demonstrates the value of the novel methodology for 
footfall variability.  
 
Variability of step length and step width contribute to footfall variability in the current method in 
that fluctuations in step length or step width cause an individual’s footfall pattern to move away 
from a simple sinusoid. However, CV of spatiotemporal gait parameters did not distinguish fall 
groups. This result was surprising because previous reports in other clinical populations found 
relationships between traditional variability metrics and falls
16-18
. This indicates that the additive 
effects of step length and step width variability, quantified by FV, may be more sensitive to falls 
than individual spatiotemporal gait parameters. In addition to variation of step length and width, 
a third potential contributor to footfall variability is an individual’s ability to walk straight. This 
facet of gait variability is not captured by typical analysis of spatiotemporal gait parameters, but 
is encompassed in the current method. Drifting from side to side during ambulation causes 
deviation in an individual’s footfall pattern away from a simple sinusoid. An inability to walk 
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straight could arise from sensory and balance impairment in MS, which are also related to falls in 
MS
8
. 
 
Examination of the physical meaning of footfall variability yields a logical connection between 
FV and falls. Increased footfall variability indicates reduced control over the placement of an 
individual’s steps during walking. This could lead to falling in multiple ways. First, an individual 
with high footfall variability may be more likely to have a step land in an unstable location that 
could cause the center of mass to leave the base of support, resulting in a fall. Second, lack of 
control of where your steps land, reflected by increased footfall variability, could result in lower 
ability to avoid obstacles that could result in tripping. 
 
Differences in gait variability between fall groups and healthy controls were also assessed using 
traditional parameters as well as footfall variability. Both recurrent and non fallers with MS 
demonstrated greater FV, step length CV, and step time CV than controls, but showed no 
differences in step width CV. These results are congruent with previous reports that show 
increased gait variability in people with MS compared to healthy controls
19-22
. There are several 
possible explanations for increased gait variability, including footfall variability, in persons with 
MS compared to controls. Increases in spasticity
28
 and fatigue
29
 and declines in muscle strength
30
 
have been previously associated with gait impairment in MS and could be related to elevated gait 
variability
31
. Specific relationships between gait variability and underlying factors warrant future 
investigation. 
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The results of the current study are also congruent with previous literature on gait and falls in 
MS. Both MS groups walked slower than controls
21,32,33
. The recurrent fallers with MS walked 
significantly slower than the non fallers with MS. This reflects more impaired gait in the 
recurrent fallers group, which is congruent with previous literature associating gait impairment 
with falls in MS
6,8
.  In addition to footfall variability, disability status (EDSS) distinguished 
recurrent from non fallers with MS. This is also congruent with previous reports
5,8
 that showed 
associations between disability status and falls in MS. It has been reported that approximately 
50% of people with MS fall in a given year
5-8
. In our sample, 53% of individuals (25/47) 
reported at least 1 fall in the previous 12 months. Of the persons with MS who reported falling in 
our sample, 76% (19/25) were recurrent fallers, which is also congruent with previous literature 
reporting 33-79% of fallers with MS are recurrent fallers
6,8,9
. Overall, this suggests that our MS 
sample was representative of the MS population. 
 
There are limitations to the current study. First of all, footfall variability was quantified using a 
novel metric. While the current observations demonstrate the potential for the FV method to 
distinguish fallers from non fallers with MS, future work must be done to assess the reliability of 
this metric. A second limitation of this study was its cross-sectional nature, which included fall 
history being self reported. If the current method for quantifying FV is proven to be valid and 
reliable, a prospective study should be performed to assess the potential value of FV as a 
predictive measure for falls in MS. 
 
In summary, footfall variability is elevated in MS compared to controls and recurrent fallers with 
MS demonstrate greater footfall variability than non fallers with MS. The novel method used for 
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quantifying footfall variability requires further testing to determine reliability. However, the lack 
of differences between fall groups in variability of spatiotemporal gait parameters reinforces the 
need to develop new tools for analyzing gait variability. Potential mechanisms and underlying 
factors driving gait variability in MS should also be investigated.  
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4.7 Figures 
 
 
 
Figure 4.1. COP coordinates of each footfall from a healthy control participant’s walking trial 
(left to right) are shown. This footfall pattern was best fit with a 1
st
 order Fourier series (FV=1). 
 
 
 
 
 
Figure 4.2. An example of a non faller with MS’ footfall pattern is shown (walking left to right), 
which was best fit with a 3
rd
 order Fourier series (FV=3). 
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Figure 4.3. A recurrent faller with MS’ footfall pattern is shown with (A) a 1st order Fourier 
series fit, which did not adequately capture footfall placement, and (B) a 7
th
 order Fourier series 
(FV=7), which was considered to be the best fit. 
  
(A) 
(B) 
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4.8 Tables  
Table 4.1. Participant characteristics for both MS fall groups and controls. 
 Non Fallers 
w/ MS 
Recurrent 
Fallers w/ MS 
Controls 
N 22 19 20 
Age [years] 51.2 ± 12.1 54.4 ± 9.8 50.9 ± 8.7 
Gender [F / M] 21 / 1 15 / 4 16 / 4 
EDSS [-] 3.9 ± 1.5 4.9 ± 1.3 - 
Walking speed [m/sec] 1.1 ± 0.3 0.9 ± 0.3 1.5 ± 0.1 
 
 
 
Table 4.2. Gait variability results for both MS fall groups and controls. Coefficient of variation 
(CV) of step width, step length, and step time and footfall variability (FV) are reported. Results 
of the one-way ANOVA are also reported. Superscript a, b, and c denote specific group 
differences from post hoc analysis. 
 Non Fallers 
w/ MS 
Recurrent 
Fallers w/ MS 
Controls F(2,48), p 
Step width CV [%] 21.2 ± 10.3 21.8 ± 17.4 18.2 ± 12.6 0.291, 0.749 
Step length CV
 a b
 [%] 4.6 ± 3.0 6.0 ± 3.3 1.9 ± 0.7 7.024, 0.002 
Step time CV
 a b
 [%] 4.5 ± 2.5 5.6 ± 3.4 4.4 ± 3.0 7.376, 0.002 
FV
a b c
 [-] 5.8 ± 2.2 7.0 ± 1.6 1.3 ± 0.5 34.612, <0.001 
a - Difference between non fallers and controls, b – Difference between recurrent fallers and 
controls, c - Difference between MS fall groups (p<0.05). 
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CHAPTER 5 
 
 
 
CONCLUSION 
 
 
 
 5.1 Summary and future directions 
 
 
 
In summary, the purpose of the investigations contained within this thesis was to address 
unanswered questions concerning gait variability in persons with multiple sclerosis (MS). While 
there have been previous studies documenting gait variability in MS
1-5
, they do not provide a 
complete picture. The current investigations provide additional documentation to existing work 
on gait variability in MS compared to healthy controls and address several unanswered questions 
about gait variability in MS. 
 
Previous reports on gait variability in MS report that persons with MS have elevated variability 
of step and single-support time
1
, step length
4
, and hip, knee, and ankle angles
2
 compared to 
healthy controls. Concerning variability of spatiotemporal gait parameters, our results (Chapter 
2) were congruent with previous reports
1,4
 demonstrating that people with MS have greater 
variability of step length and step time than healthy controls. In that investigation, we had a 
sample size (N=88 with MS) that was much greater than the previous reports
1,4
 using similar 
metrics (N = 9 and 43 people with MS). Our investigation also included people with MS with a 
wider range of disability status than previous reports
1,4
. Our results (Chapter 3) concerning 
variability of leg joint angles were not congruent with the previous literature
2
 who demonstrated 
greater variability of hip, knee, and ankle angle in MS compared to controls. Our results, using 
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the same metric (standard deviation), showed similar values for standard deviation of knee and 
ankle angles in the MS group, but we showed no differences between the MS and healthy control 
groups.  
 
The first novel question addressed in this thesis was the role of disability status (Expanded 
Disability Status Scale
6
, EDSS) in variability of spatiotemporal gait parameters in persons with 
MS (Chapter 2). A previous study
3
 demonstrated that a small group (N=5) of people with MS 
with EDSS<4.0 had significantly less variability of stride length than a similarly sized group of 
people with MS with EDSS≥4.0. We expanded that result in much a larger sample (N=88) to 
show that variability of step length as well as step time correlate positively to EDSS. We also 
demonstrated that step width variability correlates negatively to EDSS, where the previous 
report
3
 found no differences in step width variability between MS disability groups. 
 
A second novel question concerning gait variability in MS that was addressed was the role of 
walking speed in gait variability (Chapter 3). We demonstrated that people with MS experience a 
significant change in variability at the ankle as they increase their walking speed from 75% of 
their preferred speed to 125% of their preferred speed. This pattern of change was similar to 
previous research
7
 that demonstrated that people without MS experience reductions in magnitude 
of gait variability as walking speed is increased. 
 
We also examined potential connections between gait variability and fall history in MS. Gait 
variability has been previously linked to falls in other populations
8-11
, but not in MS. In chapter 
4, it was demonstrated that recurrent fallers with MS exhibit greater variability of the placement 
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of their footfalls than non fallers with MS and healthy controls. This report utilized a novel 
metric that quantified footfall variability by the number of harmonic terms required to accurately 
map the AP-ML position of footfalls. The reliability of this method and the associations between 
footfall variability, indexed in this way, and other gait variability metrics should be investigated 
in the future. 
 
Despite the novel observations reported in this thesis, important questions concerning gait 
variability in MS remain. As previously stated, the reliability and validity of methods for 
quantifying footfall placement variability need to be evaluated. Also, a larger study should be 
done to re-examine differences between people with MS and healthy controls with regards to 
variability of joint angles in the legs. Future investigations should also explore relationships 
between gait variability and other factors that have been related to gait impairment in MS such as 
fatigue
12,13
, muscle weakness
14,15
, and spasticity
16
. 
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